We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.3B
AUM Growth
+$198M
Cap. Flow
+$75.1M
Cap. Flow %
5.78%
Top 10 Hldgs %
26.62%
Holding
265
New
28
Increased
44
Reduced
124
Closed
7

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$2.74M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$1.4M
3
AAPL icon
Apple
AAPL
+$1.21M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.16M
5
AFL icon
Aflac
AFL
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Healthcare 14.97%
3 Financials 8.17%
4 Industrials 8.04%
5 Consumer Discretionary 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
76
Norfolk Southern
NSC
$75.1B
$4.31M 0.33%
18,121
PH icon
77
Parker-Hannifin
PH
$135B
$4.3M 0.33%
15,800
-25
-0.2% -$6.19K
CMCSA icon
78
Comcast
CMCSA
$90B
$4.19M 0.32%
80,043
-5,284
-6% -$253K
KO icon
79
Coca-Cola
KO
$375B
$3.8M 0.29%
69,356
-4,200
-6% -$217K
INTC icon
80
Intel
INTC
$513B
$3.72M 0.29%
74,609
-7,774
-9% -$380K
SRCL
81
DELISTED
Stericycle Inc
SRCL
$3.71M 0.29%
53,534
-4,649
-8% -$318K
VIG icon
82
Vanguard Dividend Appreciation ETF
VIG
$114B
$3.69M 0.28%
26,163
+2,841
+12% +$385K
VXF icon
83
Vanguard Extended Market ETF
VXF
$31.9B
$3.63M 0.28%
22,046
+433
+2% +$64.2K
VEA icon
84
Vanguard FTSE Developed Markets ETF
VEA
$237B
$3.42M 0.26%
72,406
-421
-0.6% -$18.5K
QCOM icon
85
Qualcomm
QCOM
$176B
$3.3M 0.25%
21,690
+200
+0.9% +$27.9K
VEU icon
86
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$3.27M 0.25%
56,067
-1,096
-2% -$59.7K
CSCO icon
87
Cisco
CSCO
$479B
$3.12M 0.24%
69,759
-10,945
-14% -$450K
D icon
88
Dominion Energy
D
$59.3B
$3.12M 0.24%
41,501
-1,252
-3% -$99.5K
MIDD icon
89
Middleby
MIDD
$6.08B
$3.11M 0.24%
24,132
-2,535
-10% -$306K
GLNG icon
90
Golar LNG
GLNG
$5.13B
$3.09M 0.24%
320,170
+4,021
+1% +$34.9K
PFE icon
91
Pfizer
PFE
$153B
$3.05M 0.23%
82,840
-6,816
-8% -$250K
VXUS icon
92
Vanguard Total International Stock ETF
VXUS
$163B
$2.96M 0.23%
49,293
IFF icon
93
International Flavors & Fragrances
IFF
$21.9B
$2.95M 0.23%
27,070
+628
+2% +$70.5K
FDX icon
94
FedEx
FDX
$75.4B
$2.9M 0.22%
11,160
CL icon
95
Colgate-Palmolive
CL
$74.4B
$2.85M 0.22%
33,311
TGT icon
96
Target
TGT
$68B
$2.83M 0.22%
16,045
COST icon
97
Costco
COST
$420B
$2.79M 0.21%
7,408
+393
+6% +$147K
VGIT icon
98
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
$2.69M 0.21%
+38,742
New +$2.71M
NVO
99
Novo Nordisk
NVO
$209B
$2.69M 0.21%
76,950
IJH icon
100
iShares Core S&P Mid-Cap ETF
IJH
$127B
$2.58M 0.2%
56,215
-195
-0.3% -$8.22K

Similar funds

Boston Family Office's Q4 2020 Portfolio in Review

As of Q4 2020, Boston Family Office held 265 positions worth $1.3B, up 18% from $1.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Family Office deployed $75.1M of net new capital in Q4 2020, opening 28 new positions and adding to 44 existing holdings. Its largest new stake was Vanguard Short-Term Bond ETF: 253,733 shares worth $21M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Marsh, an estimated $2.74M trimmed.

  • Boston Family Office's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 253,733 shares worth $21M.
  • Boston Family Office added most to SolarEdge in Q4 2020, an estimated $2.89M increase.
  • Boston Family Office's biggest Q4 2020 reduction was Marsh, cutting an estimated $2.74M.
  • Boston Family Office fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $1.4M.
  • Boston Family Office's ten largest holdings make up 27% of its $1.3B portfolio in Q4 2020.
  • Boston Family Office opened 28 new positions and closed 7 in Q4 2020.
  • Boston Family Office's portfolio value rose 18% quarter-over-quarter to $1.3B.

Based on Boston Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.